As of 2024-12-14, the Intrinsic Value of Silverback Therapeutics Inc (SBTX) is
- USD. This SBTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 5.87 USD, the upside of Silverback Therapeutics Inc is
-100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
SBTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
- - - |
- |
-100.00% |
| P/E |
(19.93) - (18.49) |
(21.55) |
-467.0% |
| DDM - Stable |
(6.36) - (21.75) |
(14.05) |
-339.4% |
| DDM - Multi |
(3.07) - (8.67) |
(4.59) |
-178.2% |
SBTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
211.66 |
| Beta |
1.07 |
| Outstanding shares (mil) |
36.06 |
| Enterprise Value (mil) |
92.65 |
| Market risk premium |
5.00% |
| Cost of Equity |
11.28% |
| Cost of Debt |
5.00% |
| WACC |
7.48% |